These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37524214)

  • 21. Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation.
    Furuishi T; Sato-Hata N; Fukuzawa K; Yonemochi E
    Pharm Dev Technol; 2023; 28(3-4):309-317. PubMed ID: 36946594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Co-amorphous technology to improve dissolution and physical stability of silybin].
    Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
    Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution.
    Russo MG; Brusau EV; Ellena J; Narda GE
    Int J Pharm; 2023 Jul; 642():123053. PubMed ID: 37196883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
    Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
    An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and Evaluation of the Solubility and Oral Bioavailability of Rutin-Ethanolate Solvate.
    Liu Y; Zhao X; Zhang Q; Wang L; Li Y; Li Y
    AAPS PharmSciTech; 2020 Aug; 21(7):241. PubMed ID: 32839899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X; Xu T; Huang W; Fan B; Sheng X
    AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous improvement of solubility and permeability by fabricating binary glassy materials of Talinolol with Naringin: Solid state characterization, in-vivo in-situ evaluation.
    Teja A; Musmade PB; Khade AB; Dengale SJ
    Eur J Pharm Sci; 2015 Oct; 78():234-44. PubMed ID: 26253355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability.
    Fael H; Demirel AL
    Int J Pharm; 2021 May; 600():120448. PubMed ID: 33675920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raloxifene HCl - quercetin co-amorphous system: preparation, characterization, and investigation of its behavior in phosphate buffer.
    K S NS; Dengale SJ; Mutalik S; Bhat K
    Drug Dev Ind Pharm; 2022 Jun; 48(6):227-238. PubMed ID: 35852408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
    Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
    AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.
    Bohr A; Nascimento TL; Harmankaya N; Weisser JJ; Wang Y; Grohganz H; Rades T; Löbmann K
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation.
    Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29986403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.